CASPR2 Encephalitis Initial Symptoms

CompletedOBSERVATIONAL
Enrollment

48

Participants

Timeline

Start Date

January 11, 2021

Primary Completion Date

March 30, 2021

Study Completion Date

January 20, 2022

Conditions
CASPR2-AntibodyEncephalitis AutoimmuneParaneoplastic Syndromes
Interventions
OTHER

CASPR2 encephalitis

Defining the initial clinical symptoms and those leading to the diagnosis of CASPR2 antibody associated encephalitis. For that, we will investigate the initial cognitive status, the initial neuropsychological investigations the clinical presentation of the first seizures, and the prodromes assessed by patients at the beginning of their disease. We will also look at the initial EEG records, in order to acknowledge whether the initial cognitive symptoms may be due to unseen seizures.

Trial Locations (1)

69500

Service de Neuro-Oncologie, Hôpital Neurologique Pierre Wertheimer, Bron

All Listed Sponsors
lead

Hospices Civils de Lyon

OTHER

NCT04653571 - CASPR2 Encephalitis Initial Symptoms | Biotech Hunter | Biotech Hunter